CD38-targeted and erythrocyte membrane camouflaged nanodrug delivery system for photothermal and chemotherapy in multiple myeloma-Reference-Cited by-同舟云学术

CD38-targeted and erythrocyte membrane camouflaged nanodrug delivery system for photothermal and chemotherapy in multiple myeloma

Published:2023-08 Issue: Volume:643 Page:123241
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Zhang Fangrong^ORCID,Yang Qin,Tang Sishi,Jiang Siyi,Zhao Qiangqiang,Li Jian,Xu Cong,Liu Jing,Fu Yunfeng

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference54 articles.

1. The safety of bortezomib for the treatment of multiple myeloma;Cengiz;Expert Opin. Drug. Saf.,2018

2. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells;Chen;Int. J. Nanomed.,2015

3. Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016;Cowan;JAMA Oncol.,2018

4. Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma;de la Puente;J. Control. Release,2018

5. Advancements in nanomedicine for multiple myeloma;Detappe;Trends Mol. Med.,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment;Biomolecules;2024-08-07

2. Targeting regulated cell death (RCD) in hematological malignancies: Recent advances and therapeutic potential;Biomedicine & Pharmacotherapy;2024-06

3. The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment;Frontiers in Pharmacology;2024-04-16

4. New insights into red blood cells in tumor precision diagnosis and treatment;Nanoscale;2024